Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
485.4 INR | -0.41% | -0.50% | +34.39% |
05-20 | Solara Active Pharma Gets Zero Observations from US FDA for Andhra Pradesh, India Unit | MT |
05-10 | Solara Active Pharma to Raise 4.50 Billion Via Rights Issue | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+34.39% | 211M | |
+37.78% | 723B | |
+31.26% | 598B | |
-3.51% | 364B | |
+19.94% | 331B | |
+5.14% | 288B | |
+16.38% | 244B | |
-4.83% | 208B | |
+10.09% | 210B | |
+9.32% | 169B |
- Stock Market
- Equities
- SOLARA Stock
- News Solara Active Pharma Sciences Limited
- Transcript : Solara Active Pharma Sciences Limited, Q2 2023 Earnings Call, Nov 09, 2022